Needle Stick Safety Issues with Prefilled Syringe Technology

As the pharmaceutical industry continues to seek out drug delivery methods that improve safety and efficiency while reducing costs, the traditional multidose or single-dose vial format for vaccines and injectables is starting to show its age.
Developed markets are increasingly turning to packaging vaccines in prefilled, single-use syringes, with more and more companies recognising the benefits that come from this area’s innovations. Prefilled syringes have been used to delivery drug categories like vaccines, therapeutic proteins, blood stimulants, erythroproteins and more.
Reports acknowledge that the market’s continued growth will have to be driven by continuing improvements to syringe technologies and materials, making prefilled syringes better, safer and more convenient than ever before.
Fortunately, this sector is abuzz with development activity seeking to improve the technology behind prefilled syringes for the benefit of the pharmaceutical industry and the patients it serves (patients particularly stand to benefit from advances in the related field of self-injection technologies).
Here, we profile the range of benefits that modern prefilled syringes are bringing to the market, and check out some of the sharpest developments in this area.
The growth of the prefilled market
The growing popularity of this drug delivery route for injectables has been noted by UK-based business analyst Visiongain, which released a report in June 2011 predicting that global revenues from prefilled syringe technology would grow from $2.7bn in 2010 to $3.9bn in 2015.
“The advantages are great, with prefilled syringes taking over from traditional formats,” said Visiongain’s healthcare reports editor Dr Gordon Low. “Prefillable syringes constitute one of the fastest-growing markets in the drug delivery and pharmaceutical packaging industries.”
Reports of rapid growth in the prefilled syringe market have not gone unnoticed by device manufacturers. In November 2010, for example, German healthcare device manufacturer Gerresheimer began work to add a fourth production line dedicated to prefilled syringes to its plant in Bünde.
The company was prompted to make the €20m investment out of a desire to tap into the prefilled market’s double-digit annual growth rates. The plant’s prefilled syringe production line is due to join its three ready-to-fill lines in 2012.
Market Trends
Why the Globe Prefilled Safety Syringe Technology?
What are the most important features of the prefilled safety syringe with auto-retractable needle?
What distinguishes this product from competing safety syringes?
- Integrated Needle Stick Prevention with Patented Vacuum Needle retraction technology
- Adaptable for glass and plastic syringe barrels.
- Cost Competitive (compared to regular syringes)
- Dual Chamber version maintains the individual contents in completely separate chambers and allows for drug and dissolvent/dispersant to be separated until use
- Allows quick and complete combination of powder/liquid mixed for low volume of parenteral
- Fully OSHA safety compliant
- Reduce error and contamination risk
- Compatible with most injectables
- Increased dosage compliance
- Enhanced efficiency
- Extended shelf life
- Ease of us